<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36881218</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-2649</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation</Title><ISOAbbreviation>Qual Life Res</ISOAbbreviation></Journal><ArticleTitle>Assessing the psychometric properties of quality of life measures in individuals with amyotrophic lateral sclerosis: a systematic review.</ArticleTitle><Pagination><StartPage>2447</StartPage><EndPage>2462</EndPage><MedlinePgn>2447-2462</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11136-023-03377-2</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease in adults. There are many patient-reported outcome measures (PROMs) for measuring quality of life (QoL) and health-related QoL (HRQoL) within this population; however, there is limited consensus regarding&#xa0;which are most valid, reliable, responsive, and interpretable. This systematic review assesses the psychometric properties and interpretability of QoL and HRQoL PROMs for individuals with ALS.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This review was conducted following the Consensus-based Standards for the selection of health Measurement Instruments&#xa0;(COSMIN) methodology for systematic reviews of PROMs. MEDLINE, EMBASE, and CINAHL databases were searched. Studies were included if their aim was to evaluate one or more psychometric properties or the interpretability of QoL or HRQoL PROMs in individuals with ALS.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We screened 2713 abstracts, reviewed 60 full-text articles, and included 37 articles. Fifteen PROMs were evaluated including generic HRQoL (e.g., SF-36), ALS-specific HRQoL (e.g., ALSAQ-40), and individualized QoL (e.g., SEIQoL) measures. Evidence for internal consistency and test-retest reliability were acceptable. For convergent validity, 84% of hypotheses were met. For known-groups validity, outcomes were able to distinguish between healthy cohorts and other conditions. Responsiveness results ranged from low to high correlations with other measures over 3-24&#xa0;months. Evidence for content validity, structural validity, measurement error, and divergent validity was limited.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This review identified evidence in support of the ALSAQ-40 or ALSAQ-5 for individuals with ALS. These findings can&#xa0;guide healthcare practitioners when selecting evidence-based QoL and HRQoL PROMs for patients and provide researchers with&#xa0;insight into gaps in the literature.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zahir</LastName><ForeName>Faryal</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>School of Rehabilitation Science, McMaster University, 1400 Main St. W., IAHS, Hamilton, ON, L8S 1C7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Hanman</LastName><ForeName>Alicia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Rehabilitation Science, McMaster University, 1400 Main St. W., IAHS, Hamilton, ON, L8S 1C7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yazdani</LastName><ForeName>Nazmehr</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>School of Rehabilitation Science, McMaster University, 1400 Main St. W., IAHS, Hamilton, ON, L8S 1C7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>La Rosa</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Rehabilitation Science, McMaster University, 1400 Main St. W., IAHS, Hamilton, ON, L8S 1C7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sleik</LastName><ForeName>Gemma</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>School of Rehabilitation Science, McMaster University, 1400 Main St. W., IAHS, Hamilton, ON, L8S 1C7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sullivan</LastName><ForeName>Brooke</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>School of Rehabilitation Science, McMaster University, 1400 Main St. W., IAHS, Hamilton, ON, L8S 1C7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehdipour</LastName><ForeName>Ava</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Rehabilitation Science, McMaster University, 1400 Main St. W., IAHS, Hamilton, ON, L8S 1C7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malouka</LastName><ForeName>Selina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Rehabilitation Science, McMaster University, 1400 Main St. W., IAHS, Hamilton, ON, L8S 1C7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuspinar</LastName><ForeName>Ayse</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3886-0407</Identifier><AffiliationInfo><Affiliation>School of Rehabilitation Science, McMaster University, 1400 Main St. W., IAHS, Hamilton, ON, L8S 1C7, Canada. kuspinaa@mcmaster.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Qual Life Res</MedlineTA><NlmUniqueID>9210257</NlmUniqueID><ISSNLinking>0962-9343</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071066" MajorTopicYN="N">Patient Reported Outcome Measures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011594" MajorTopicYN="N">Psychometrics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Health-related quality of life</Keyword><Keyword MajorTopicYN="N">Interpretability</Keyword><Keyword MajorTopicYN="N">Psychometric properties</Keyword><Keyword MajorTopicYN="N">Quality of life</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>7</Day><Hour>11</Hour><Minute>17</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36881218</ArticleId><ArticleId IdType="doi">10.1007/s11136-023-03377-2</ArticleId><ArticleId IdType="pii">10.1007/s11136-023-03377-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van Es, M. A., Hardiman, O., Chio, A., Al-Chalabi, A., Pasterkamp, R. J., Veldink, J. H., &amp; van den Berg, L. H. (2017). Amyotrophic lateral sclerosis. Lancet,&#xa0;390(10107), 2084&#x2013;2098.</Citation><ArticleIdList><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman, O., Al-Chalabi, A., Chio, A., Corr, E. M., Logroscino, G., Robberecht, W., Shaw, P. J., Simmons, Z., &amp; van den Berg, L. H. (2017). Amyotrophic lateral sclerosis. Nature Reviews. Disease Primers, 3, 17085.</Citation><ArticleIdList><ArticleId IdType="pubmed">29052611</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladman, M., &amp; Zinman, L. (2015). The economic impact of amyotrophic lateral sclerosis: A systematic review. Expert Review of Pharmacoeconomics &amp; Outcomes Research, 15(3), 439&#x2013;450.</Citation></Reference><Reference><Citation>Longinetti, E., &amp; Fang, F. (2019). Epidemiology of amyotrophic lateral sclerosis: An update of recent literature. Current Opinion in Neurology, 32(5), 771&#x2013;776.</Citation><ArticleIdList><ArticleId IdType="pubmed">31361627</ArticleId><ArticleId IdType="pmc">6735526</ArticleId></ArticleIdList></Reference><Reference><Citation>Talbott, E. O., Malek, A. M., &amp; Lacomis, D. (2016). The epidemiology of amyotrophic lateral sclerosis. Handbook of Clinical Neurology, 138, 225&#x2013;238.</Citation><ArticleIdList><ArticleId IdType="pubmed">27637961</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogden, A. (2014). Optimizing patient autonomy in amyotrophic lateral sclerosis: Inclusive decision-making in multidisciplinary care. Neurodegenerative Disease Management, 4(1), 1&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">24640972</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkinson, C., Fitzpatrick, R., &amp; Jenkinson, D. (2000). Health status measurement in neurological disorders. Radcliffe Medical Press.</Citation></Reference><Reference><Citation>Simmons, Z. (2015). Patient-perceived outcomes and quality of life in ALS. Neurotherapeutics, 12(2), 394&#x2013;402.</Citation><ArticleIdList><ArticleId IdType="pubmed">25502407</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopalakrishnan, S., &amp; Ganeshkumar, P. (2013). Systematic reviews and meta-analysis: understanding the best evidence in primary healthcare. J Family Med Prim Care, 2(1), 9&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">24479036</ArticleId><ArticleId IdType="pmc">3894019</ArticleId></ArticleIdList></Reference><Reference><Citation>Lidwine, B., Mokkink, C. A. P., Donald, L. P., Jordi, A., Lex, M. B., de Vet Henrica, C. W., Caroline, B. T. (2018). COSMIN manual for systematic reviews of PROMs COSMIN methodology for systematic reviews of Patient-Reported Outcome Measures (PROMs) user manual, pp. 1&#x2013;78.</Citation></Reference><Reference><Citation>Terwee, C. B., Jansma, E. P., Riphagen, I. I., &amp; de Vet, H. C. (2009). Development of a methodological PubMed search filter for finding studies on measurement properties of measurement instruments. Quality of Life Research, 18(8), 1115&#x2013;1123.</Citation><ArticleIdList><ArticleId IdType="pubmed">19711195</ArticleId><ArticleId IdType="pmc">2744791</ArticleId></ArticleIdList></Reference><Reference><Citation>Mokkink, L. B., de Vet, H. C. W., Prinsen, C. A. C., Patrick, D. L., Alonso, J., Bouter, L. M., &amp; Terwee, C. B. (2018). COSMIN risk of bias checklist for systematic reviews of patient-reported outcome measures. Quality of Life Research, 27(5), 1171&#x2013;1179.</Citation><ArticleIdList><ArticleId IdType="pubmed">29260445</ArticleId></ArticleIdList></Reference><Reference><Citation>de Vet, H. C., Terwee, C. B., Mokkink, L. B., &amp; Knol, D. L. (2011). Measurement in medicine: A practical guide. Cambridge Universtiy Press.</Citation></Reference><Reference><Citation>Deeks, J. J. (2011). Chapter 9: Analysing data and undertaking meta-analyses. In Cochrane handbook for systematic reviews of interventions version 5.1.0.</Citation></Reference><Reference><Citation>Sch&#xfc;nemann, H. B. J., Guyatt, G., &amp; Oxman, A. (2013). GRADE handbook for grading quality of evidence and strength of recommendations. In H. Sch&#xfc;nemann, J. Bro&#x17c;ek, G. Guyatt &amp; A. Oxman (Eds.).</Citation></Reference><Reference><Citation>Alankaya, N., Tulek, Z., Ozakgul, A., Kaya, A., &amp; Dik, A. (2019). Validity and reliability of the Turkish version of the amyotrophic lateral sclerosis assessment questionnaire. The Journal of Neuroscience Nursing, 51(5), 253&#x2013;258.</Citation><ArticleIdList><ArticleId IdType="pubmed">31469706</ArticleId></ArticleIdList></Reference><Reference><Citation>Gayoso, M. V., Domingues, F. S., de Barros, G. A. M., Franca Junior, M. C., Felgoise, S. H., &amp; Oliveira, A. S. B. (2020). Cross-cultural adaptation and validation for the Brazilian population of the instrument amyotrophic lateral sclerosis-specific quality of life-short form (ALSSQOL-SF). Quality of Life Research, 29(3), 805&#x2013;813.</Citation><ArticleIdList><ArticleId IdType="pubmed">31664605</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters, N., Dal Bello-Haas, V., Packham, T., Chum, M., O&#x2019;Connell, C., Johnston, W. S., MacDermid, J. C., Turnbull, J., Van Damme, J., &amp; Kuspinar, A. (2021). Do generic preference-based measures accurately capture areas of health-related quality of life important to individuals with amyotrophic lateral sclerosis: A content validation study. Patient related outcome measures, 12(101551170), 191&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pubmed">34211304</ArticleId><ArticleId IdType="pmc">8242131</ArticleId></ArticleIdList></Reference><Reference><Citation>De Marchi, F., Berry, J. D., Caldwell, S., Ellrodt, A., Scalia, J., Burke, K., Fang, T., Chan, J., Clark Sisodia, R., Schwamm, L. H., Moura, L. M. V. R., &amp; Paganoni, S. (2020). Patient reported outcome measures (PROMs) in amyotrophic lateral sclerosis. Journal of Neurology, 267(6), 1754&#x2013;1759.</Citation><ArticleIdList><ArticleId IdType="pubmed">32125520</ArticleId></ArticleIdList></Reference><Reference><Citation>McColl, E., Shaw, P. J., Gibson, G. J., &amp; Bourke, S. C. (2004). Validation of quality of life instruments in ALS. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 5(1), 55&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">15204025</ArticleId></ArticleIdList></Reference><Reference><Citation>Neudert, C., Wasner, M., &amp; Borasio, G. D. (2004). Individual quality of life is not correlated with health-related quality of life or physical function in patients with amyotrophic lateral sclerosis. Journal of Palliative Medicine, 7(4), 551&#x2013;557.</Citation><ArticleIdList><ArticleId IdType="pubmed">15353099</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke, S., Hickey, A., O&#x2019;Boyle, C., &amp; Hardiman, O. (2001). Assessing individual quality of life in amyotrophic lateral sclerosis. Quality of Life Research, 10(2), 149&#x2013;158.</Citation><ArticleIdList><ArticleId IdType="pubmed">11642685</ArticleId></ArticleIdList></Reference><Reference><Citation>Neudert, C., Wasner, M., &amp; Borasio, G. D. (2001). Patients&#x2019; assessment of quality of life instruments: A randomised study of SIP, SF-36 and SEIQoL-DW in patients with amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 191(1&#x2013;2), 103&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pubmed">11676999</ArticleId></ArticleIdList></Reference><Reference><Citation>Tramonti, F., Bongioanni, P., Di Bernardo, C., Davitti, S., &amp; Rossi, B. (2012). Quality of life of patients with amyotrophic lateral sclerosis. Psychology, Health &amp; Medicine, 17(5), 621&#x2013;628.</Citation></Reference><Reference><Citation>Forshew, D. A., &amp; Bromberg, M. B. (2002). Comparison of instruments addressing quality of life in patients with ALS and their caregivers. Neurology, 58(2), 320&#x2013;322.</Citation><ArticleIdList><ArticleId IdType="pubmed">11805269</ArticleId></ArticleIdList></Reference><Reference><Citation>Felgoise, S. H., Stewart, J. L., Bremer, B. A., Walsh, S. M., Bromberg, M. B., &amp; Simmons, Z. (2009). The SEIQoL-DW for assessing quality of life in ALS: Strengths and limitations. Amyotrophic Lateral Sclerosis, 10(5&#x2013;6), 456&#x2013;462.</Citation><ArticleIdList><ArticleId IdType="pubmed">19922140</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakobsson Larsson, B., Ozanne, A. G., Nordin, K., &amp; Nygren, I. (2017). A prospective study of quality of life in amyotrophic lateral sclerosis patients. Acta neurologica Scandinavica, 136(6), 631&#x2013;638.</Citation><ArticleIdList><ArticleId IdType="pubmed">28523721</ArticleId></ArticleIdList></Reference><Reference><Citation>Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hr&#xf3;bjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., et al. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, n71.</Citation></Reference><Reference><Citation>Hong, G.-R.S., Kim, J. A., Oh, J., &amp; Kim, S. H. (2017). Translation and psychometric evaluation of a Korean version of the amyotrophic lateral sclerosis-specific quality of life-revised. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 18(1&#x2013;2), 92&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">27922756</ArticleId></ArticleIdList></Reference><Reference><Citation>Mooij, R., Veldink, J. H., Van Den Berg, L. H., Maessen, M., Maille, R., Post, M. W., &amp; Lindeman, E. (2007). Validity of the Dutch version of the amyotrophic lateral sclerosis assessment questionnaire, ALSAQ-40, ALSAQ-5. Amyotrophic Lateral Sclerosis, 8(2), 96&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">17453637</ArticleId></ArticleIdList></Reference><Reference><Citation>Felgoise, S. H., Feinberg, R., Stephens, H. E., Simmons, Z., Barkhaus, P., Boylan, K., Caress, J., Clawson, L. L., Elman, L., McCluskey, L. E. O., Goutman, S. A., Russell, J., Tiryaki, E., &amp; Weiss, M. (2018). Amyotrophic lateral sclerosis-specific quality of life- short form (ALSSQOL-SF): A brief, reliable, and valid version of the ALSSQOL-R. Muscle and Nerve, 58(5), 646&#x2013;654.</Citation><ArticleIdList><ArticleId IdType="pubmed">30028537</ArticleId></ArticleIdList></Reference><Reference><Citation>Peseschkian, T., Schonfelder, E., Heinrich, F., Osmanovic, A., Petri, S., Schreiber-Katz, O., Cordts, I., Deschauer, M., Lingor, P., Gunther, R., Stolte, B., Hagenacker, T., Zeller, D., Schroter, C., Weyen, U., Regensburger, M., Wolf, J., Schneider, I., Hermann, A., &#x2026; Boentert, M. (2021). A nation-wide, multi-center study on the quality of life of ALS patients in Germany. Brain Sciences, 11(3), 372.</Citation><ArticleIdList><ArticleId IdType="pubmed">33799476</ArticleId><ArticleId IdType="pmc">7998410</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkinson, C. (1999). Development and validation of a short measure of health status for individuals with amyotrophic lateral sclerosis/motor neurone disease: The ALSAQ-40. Journal of Neurology, Supplement, 246(3), 16&#x2013;21.</Citation></Reference><Reference><Citation>Jenkinson, C., Fitzpatrick, R., Brennan, C., &amp; Swash, M. (1999). Evidence for the validity and reliability of the ALS assessment questionnaire: The ALSAQ-40. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 1(1), 33&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">12365067</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkinson, C., Levvy, G., Fitzpatrick, R., &amp; Garratt, A. (2000). The amyotrophic lateral sclerosis assessment questionnaire (ALSAQ-40): Tests of data quality, score reliability and response rate in a survey of patients. Journal of the Neurological Sciences, 180(1&#x2013;2), 94&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">11090872</ArticleId></ArticleIdList></Reference><Reference><Citation>Norquist, J. M., Fitzpatrick, R., &amp; Jenkinson, C. (2004). Health-related quality of life in amyotrophic lateral sclerosis: Determining a meaningful deterioration. Quality of Life Research, 13(8), 1409&#x2013;1414.</Citation><ArticleIdList><ArticleId IdType="pubmed">15503836</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavan, K., Marangoni, B. E. M., Zinezzi, M. O., Schmidt, K. B., Oliveira, B. C., Lianza, S., &amp; Buainain, R. P. (2010). Validation of the amyotrophic lateral sclerosis assessment questionnaire (ALSAQ-40) scale in the Portuguese language. Arquivos de Neuro-Psiquiatria, 68(1), 48&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">20339652</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmieri, A., Soraru, G., D&#x2019;Ascenzo, C., Baggio, L., Ermani, M., Pegoraro, E., Angelini, C., &amp; Lombardi, L. (2010). Quality of life and motor impairment in ALS: Italian validation of ALSAQ. Neurological Research, 32(1), 32&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">20092693</ArticleId></ArticleIdList></Reference><Reference><Citation>Salas, T., Mora, J., Esteban, J., Rodriguez, F., Diaz-Lobato, S., &amp; Fajardo, M. (2008). Spanish adaptation of the amyotrophic lateral sclerosis questionnaire ALSAQ-40 for ALS patients. Amyotrophic Lateral Sclerosis, 9(3), 168&#x2013;172.</Citation><ArticleIdList><ArticleId IdType="pubmed">18574761</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamshiri, H., Eshraghian, M. R., Ameli, N., &amp; Nafissi, S. (2013). Validation of the Persian version of the 40-item amyotrophic lateral sclerosis assessment questionnaire. Iranian journal of neurology, 12(3), 102&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pubmed">24250914</ArticleId><ArticleId IdType="pmc">3829291</ArticleId></ArticleIdList></Reference><Reference><Citation>Felgoise, S. H., Bremer, B. A., Walsh, S. M., Hufford, D. J., Bromberg, M. B., David, W., Forshew, D. A., Heiman-Patterson, T. D., Lai, E. C., McCluskey, L., &amp; Simmons, Z. (2006). The ALSSQOL: Balancing physical and nonphysical factors in assessing quality of life in ALS. Neurology, 67(9), 1659&#x2013;1664.</Citation><ArticleIdList><ArticleId IdType="pubmed">17101900</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkinson, C., Peto, V., Hobart, J., Chandola, T., Fitzpatrick, R., &amp; Swash, M. (2002). Use of the short form health survey (SF-36) in patients with amyotrophic lateral sclerosis: Tests of data quality, score reliability, response rate and scaling assumptions. Journal of Neurology, 249(2), 178&#x2013;183.</Citation><ArticleIdList><ArticleId IdType="pubmed">11985383</ArticleId></ArticleIdList></Reference><Reference><Citation>Damiano, A. M., Patrick, D. L., Guzman, G. I., Gawel, M. J., Gelinas, D. F., Natter, H. M., &amp; Ingalls, K. K. (1999). Measurement of health-related quality of life in patients with amyotrophic lateral sclerosis in clinical trials of new therapies. Medical care, 37(1), 15&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">10413388</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruhland, J. L., Ross, M. A., Saehler, M. M., Smith, K. B., Heffner, M. L., &amp; Shields, R. K. (1998). Analysis of health-related quality of life and muscle impairment in individuals with amyotrophic lateral sclerosis using the medical outcome survey and the tufts quantitative neuromuscular exam. Archives of Physical Medicine and Rehabilitation, 79(7), 855&#x2013;862.</Citation><ArticleIdList><ArticleId IdType="pubmed">9685105</ArticleId></ArticleIdList></Reference><Reference><Citation>Golab-Janowska, M., Honczarenko, K., &amp; Stankiewicz, J. (2010). Usefulness of the ALSAQ-5 scale in evaluation of quality of life in amyotrophic lateral sclerosis. Neurologia i Neurochirurgia Polska, 44(6), 560&#x2013;566.</Citation><ArticleIdList><ArticleId IdType="pubmed">21225518</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkinson, C., &amp; Fitzpatrick, R. (2001). Reduced item set for the amyotrophic lateral sclerosis assessment questionnaire: Development and validation of the ALSAQ-5. Journal of Neurology Neurosurgery and Psychiatry, 70(1), 70&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">11118250</ArticleId><ArticleId IdType="pmc">1763474</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkinson, C., Norquist, J. M., &amp; Fitzpatrick, R. (2003). Deriving summary indices of health status from the Amyotrophic Lateral Sclerosis Assessment Questionnaires (ALSAQ-40 and ALSAQ-5). Journal of Neurology Neurosurgery and Psychiatry, 74(2), 242&#x2013;245.</Citation><ArticleIdList><ArticleId IdType="pubmed">12531959</ArticleId><ArticleId IdType="pmc">1738302</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkinson, C., Fitzpatrick, R., Swash, M., &amp; Jones, G. (2007). Comparison of the 40-item amyotrophic lateral sclerosis assessment questionnaire (ALSAQ-40) with a short-form five-item version (ALSAQ-5) in a longitudinal survey. Clinical Rehabilitation, 21(3), 266&#x2013;272.</Citation><ArticleIdList><ArticleId IdType="pubmed">17329284</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith, P. S., Crossley, B., Greenberg, J., Wilder, C., &amp; Carroll, B. (2000). Agreement among three quality of life measures in patients with ALS. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 1(4), 269&#x2013;275.</Citation><ArticleIdList><ArticleId IdType="pubmed">11465020</ArticleId></ArticleIdList></Reference><Reference><Citation>Bromberg, M. B., Anderson, F., Davidson, M., &amp; Miller, R. G. (2001). Assessing health status quality of life in ALS: Comparison of the SIP/ALS-19 with the ALS functional rating scale and the short form-12 health surveyTM. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 2(1), 31&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">11465931</ArticleId></ArticleIdList></Reference><Reference><Citation>McGuire, D., Garrison, L., Armon, C., Barohn, R., Bryan, W., Miller, R., Parry, G., Petajan, J., &amp; Ross, M. (1996). Relationship of the tufts quantitative neuromuscular exam (TQNE) and the sickness impact profile (SIP) in measuring progression of ALS. SSNJV/CNTF ALS Study Group. Neurology, 46(5), 1442&#x2013;1444.</Citation><ArticleIdList><ArticleId IdType="pubmed">8628496</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkinson, C., Fitzpatrick, R., Peto, V., &amp; Swash, M. (2000). The ALS health profile study: Quality of life of amyotrophic lateral sclerosis patients and carers in Europe. Journal of Neurology, 247(11), 835&#x2013;840.</Citation><ArticleIdList><ArticleId IdType="pubmed">11151414</ArticleId></ArticleIdList></Reference><Reference><Citation>Epton, J., Harris, R., &amp; Jenkinson, C. (2009). Quality of life in amyotrophic lateral sclerosis/motor neuron disease: A structured review. Amyotrophic Lateral Sclerosis, 10(1), 15&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">18752087</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartmaier, S. L., Rhodes, T., Cook, S. F., Schlusser, C., Chen, C., Han, S., Zach, N., Murthy, V., &amp; Dav&#xe9;, S. (2022). Qualitative measures that assess functional disability and quality of life in ALS. Health and Quality of Life Outcomes. https://doi.org/10.1186/s12955-022-01919-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-022-01919-9</ArticleId><ArticleId IdType="pubmed">35062955</ArticleId><ArticleId IdType="pmc">8781297</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwok, E. Y. L., Rosenbaum, P., Thomas-Stonell, N., &amp; Cunningham, B. J. (2021). Strengths and challenges of the COSMIN tools in outcome measures appraisal: A case example for speech-language therapy. International Journal of Language &amp; Communication Disorders, 56(2), 313&#x2013;329.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>